InMed Pharmaceuticals (INM) Return on Sales (2021 - 2025)

InMed Pharmaceuticals has reported Return on Sales for 5 years, with the latest figure at 0.02% in Q4 2025.

• For the quarter ending Q4 2025, Return on Sales changed 0.0% year-over-year to 0.02%; the trailing twelve-month figure through Dec 2025 stood at 0.01% (up 1.0% YoY), and the FY2025 full-year result was 0.02%, changed 0.0% from the prior year.
• Return on Sales for Q4 2025 stood at 0.02%, down from 0.02% in the prior quarter.
• The five-year high for Return on Sales was 0.0% in Q1 2025, with the low at 0.16% in Q4 2021.
• Historically, Return on Sales has averaged 0.04% across 5 years, with a median of 0.02% in 2023.
• Annual changes were most pronounced in 2023 — Return on Sales gained 15 bps — and 2024, when it slipped 1 bps.
• InMed Pharmaceuticals' Return on Sales stood at 0.16% in 2021, then jumped by 72 bps to 0.04% in 2022, then surged by 73 bps to 0.01% in 2023, then slumped by 94 bps to 0.02% in 2024, then decreased by 7 bps to 0.02% in 2025.
• The last three Return on Sales figures came in at 0.02% (Q4 2025), 0.02% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.